Luna, Anaskie Kassilda M.

HRN: 24-44-07  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/20/2024
CEFTRIAXONE 1G (VIAL)
10/20/2024
10/27/2024
IV
2g
Q 24
Acute Pyelonephritis
Waiting Final Action 
10/22/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/22/2024
10/28/2024
IV
250mg
Q8
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: